Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
4.790
-0.210 (-4.20%)
Feb 21, 2025, 4:00 PM EST - Market closed
Silence Therapeutics Employees
Silence Therapeutics had 109 employees as of December 31, 2023. The number of employees decreased by 13 or -10.66% compared to the previous year.
Employees
109
Change (1Y)
-13
Growth (1Y)
-10.66%
Revenue / Employee
$199,754
Profits / Employee
-$723,788
Market Cap
226.16M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
SLN News
- 9 days ago - Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025 - Business Wire
- 2 months ago - Top 3 Health Care Stocks That May Explode In Q4 - Benzinga
- 2 months ago - Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting - Business Wire
- 3 months ago - Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 3 months ago - Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst - Benzinga
- 3 months ago - Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga
- 3 months ago - Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting - Business Wire
- 3 months ago - Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Business Wire